发明名称 Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
摘要 Compounds of formula (I), processes for their preparation and their use as CNS agents are disclosed, in which R<a> is a group of formula (i), in which P<1> is phenyl, bicyclic aryl, a 5- to 7-membered heterocyclic ring containing 1 to 3 heteroatoms selected from oxygen, nitrogen and sulphur, or a bicyclic heterocyclic ring containing 1 to 3 heteroatoms selected from oxygen, nitrogen and sulphur; R<1> is hydrogen, halogen, C1-6alkyl, C3-6cycloalkyl, COC1-6alkyl, C1-6alkoxy, hydroxy, hydroxyC1-6alkyl, hydroxyC1-6alkoxy, C1-6alkoxyC1-6alkoxy, C1-6alkanoyl, nitro, trifluoromethyl, cyano, SR<9>, SOR<9>, SO2R<9>, SO2NR<1O>R<11>, CO2R<10>, CONR<10>R<11>, CO2NR<10>R<11>, CONR<10>(CH2)cCO2R<11>, (CH2)cNR<10>R<11>, (CH2)cCONR<10>R<11>, (CH2)cNR<10>COR<11>, (CH2)cCO2C1-6alkyl, CO2(CH2)cOR<10>, NR<10>R<11>, NR<10>CO2R<11>, NR<10>CONR<10>R<11>, CR<10>=NOR<11>, NR<10>COOR<11>, CNR<10>=NOR<11>, where R<10> and R<11> are independently hydrogen or C1-6alkyl and c is 1 to 4; R<2> is hydrogen, halogen, C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkenyl, C1-6alkoxy, acyl, aryl, acyloxy, hydroxy, nitro, trifluoromethyl, cyano, CO2R<10>, CONR<10>R<11>, NR<10>R<11> where R<10> and R<11> are as defined for R<1>; a is 1, 2 or 3; or R<a> is a group of formula (ii), wherein P<2> and P<3> are independently phenyl, bicyclic aryl, a 5- to 7-membered heterocyclic ring containing 1 to 3 heteroatoms selected from oxygen, nitrogen and sulphur, or a bicyclic heterocyclic group containing 1 to 3 heteroatoms selected from oxygen, nitrogen or sulphur; A is a bond or oxygen, S(O)m where m is 0 to 2, carbonyl, CH2 or NR<4> where R<4> is hydrogen or C1-6alkyl; R<1> is as defined above for formula (I) or R<1> is an optionally substituted 5 to 7-membered heterocyclic ring containing 1 to 3 heteroatoms selected from oxygen, nitrogen or sulphur; R<2> and R<3> are independently hydrogen, halogen, C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkenyl, C1-6alkoxy, acyl, aryl, acyloxy, hydroxy, nitro, trifluoromethyl, cyano, CO2R<10>, CONR<10>R<11>, NR<10>R<11> where R<10> and R<11> are as defined for R<1>; and a and b are independently 1, 2 or 3; Y is -NH-, NR<5> where R<5> is C1-6alkyl, or Y is -CH2- or -O-; V is oxygen or sulphur; D is nitrogen, carbon or a CH group; W is (CR<16>R<17>)t where t is 2, 3 or 4 and R<16> and R<17> are independently hydrogen or C1-6alkyl or W is (CR<16>R<17>)u-J where u is 0, 1, 2 or 3 and J is oxygen, sulphur, CR<16>=CR<17>, CR<16>=N, =CR<16>O, =CR<16>S or =CR<16>-NR<17>; X is nitrogen or carbon; R<b> is hydrogen, halogen, hydroxy, C1-6alkyl, trifluoromethyl, C1-6alkoxy, C2-6alkenyl, C3-7cycloalkyl optionally substituted by C1-4alkyl, or aryl; R<c> is hydrogen or C1-6alkyl; and <o>.....</o> is a single bond when X is nitrogen or a single or double bond when X is carbon.
申请公布号 AU7431098(A) 申请公布日期 1998.11.27
申请号 AU19980074310 申请日期 1998.04.14
申请人 SMITHKLINE BEECHAM PLC 发明人 LARAMIE MARY GASTER;HARSHAD KANTILAL RAMI;PAUL ADRIAN WYMAN
分类号 A61K31/4545;A61K31/496;A61K31/497;A61K31/501;A61K31/506;A61P25/00;A61P43/00;C07D209/08;C07D401/10;C07D401/12;C07D401/14;C07D403/12;C07D405/12;C07D409/12;C07D413/12;C07D417/12;C07D521/00 主分类号 A61K31/4545
代理机构 代理人
主权项
地址